News
Earnings Scheduled For March 28, 2024
28 Mar 24
Earnings
OptimizeRx Earnings Preview
27 Mar 24
Earnings
OptimizeRx Reaffirms Prior Revenue In The Range Of $68M-$70M Vs $69.85M Est. And Adjusted EBITDA Estimates For FY2023
11 Mar 24
News, Guidance
RBC Capital Maintains Outperform on OptimizeRx, Raises Price Target to $17
10 Jan 24
News, Price Target, Analyst Ratings
Barclays Initiates Coverage On OptimizeRx with Equal-Weight Rating, Announces Price Target of $15
3 Jan 24
News, Price Target, Initiation, Analyst Ratings
Press releases
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
25 Mar 24
News, Press Releases
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
11 Mar 24
News, Press Releases
OptimizeRx Powers Walmart's 'Specialty Pharmacies of the Community' Outreach Effort
4 Mar 24
Health Care, Press Releases, General
OptimizeRx to Participate in Upcoming Investor Conferences
21 Feb 24
News, Press Releases
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
25 Jan 24
Press Releases
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
9 Jan 24
News, Health Care, Press Releases